Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q1 2019 · 10-Q
Revenue—
Net Income-$1.51M-$1.51MN/M vs Q1 2018 EPS Diluted-$0.89-$0.89N/M vs Q1 2018 Operating Income-$1,520,000N/M Operating Cash Flow-$2,008,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,008,000N/M ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end